Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Caroline ROUSSEAU; David M Goldenberg; Mathilde Colombie; Jean Charles Sebille; Philippe Meingan; Ludovic Ferrer; Pierre Baumgartner; Evelyne Cerato; Damien Masson; Mario Campone; Aurore Rauscher; Vincent Fleury; Catherine Labbe; Alain Faivre-Chauvet; Jean Sebastien Frenel; Claire Toquet; Jacques Barbet; Robert M Sharkey; Loic Campion; Francoise Kraeber-Bodere

doi:10.2967/jnumed.119.236000

OtherClinical Investigations (Human)

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Caroline ROUSSEAU, David M Goldenberg, Mathilde Colombie, Jean Charles Sebille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre-Chauvet, Jean Sebastien Frenel, Claire Toquet, Jacques Barbet, Robert M Sharkey, Loic Campion and Francoise Kraeber-Bodere

Journal of Nuclear Medicine March 2020, jnumed.119.236000; DOI: https://doi.org/10.2967/jnumed.119.236000

Caroline ROUSSEAU

1 Nuclear Medicine Unit, ICO Cancer Center; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Caroline ROUSSEAU

David M Goldenberg

2 Immunomedics, Inc., IBC Pharmaceuticals, Inc., United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathilde Colombie

3 Nuclear Medicine Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean Charles Sebille

3 Nuclear Medicine Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe Meingan

4 Radiology Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ludovic Ferrer

5 Physics Unit, ICO Cancer Center; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pierre Baumgartner

6 Pharmacy Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Evelyne Cerato

7 DRCI, University Hospital, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Damien Masson

8 Biology Unit, University Hospital, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mario Campone

9 Oncology Unit, ICO Cancer Center; CRCINA, University of Nantes, INSERM UMR1232,CNRS-ERL6001, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aurore Rauscher

6 Pharmacy Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vincent Fleury

3 Nuclear Medicine Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Catherine Labbe

4 Radiology Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alain Faivre-Chauvet

10 Nuclear Medicine Unit, University Hospital; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean Sebastien Frenel

11 Oncology Unit, ICO Cancer Center, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claire Toquet

12 Pathology Unit, University Hospital, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jacques Barbet

13 GIP Arronax, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert M Sharkey

14 Immunomedics, Inc., United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Loic Campion

15 Biometrics Unit, ICO Cancer Center; CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francoise Kraeber-Bodere

16 Nuclear Medicine Unit, ICO Cancer Center; Nuclear Medicine Unit, University Hospital; CRCINA, University of Nantes, INSERM1232, CNRS-ERL6001, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Journal of Nuclear Medicine Mar 2020, jnumed.119.236000; DOI: 10.2967/jnumed.119.236000

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Journal of Nuclear Medicine Mar 2020, jnumed.119.236000; DOI: 10.2967/jnumed.119.236000

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Nuclear Imaging of Bispecific Antibodies on the Rise
Antibody Engineering for Nuclear Imaging and Radioimmunotherapy
Pretargeting: A Path Forward for Radioimmunotherapy
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study

Google Scholar

Keywords

Oncology: Breast
PET/CT
Radioimmunoimaging
breast cancer
immuno-PET
bispecific antibody
gallium-68
pretargeting

Main menu

User menu

Search

Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Keywords